Filter announcements
Loading...
Incorporated in January 2005, Innova Captab Ltd is a pharmaceutical company is an integrated pharmaceutical company in India with a presence across the pharmaceutical value chain.
Innova Captab Limited has informed the Exchange about Investor Presentation
**Business Performance:** Innova Captab reported a strong Q4 FY26 with revenue up 42% YoY, achieving record FY26 revenue, growing 31%. Both CDMO and Branded Generics segments showed robust momentum. Exports contributed 28% to Q4 and 31% to FY26 revenue. **Growth Drivers & Key Developments:** Strategic growth is fueled by expanding...
Innova Captab posted stellar Q3 FY26 results with revenue jumping 42% YoY to ₹450.3 Cr and 9M revenue up 27% to ₹1182.2 Cr. This was fueled by strong growth in both segments: CDMO services surged 29% in Q3, while the Branded Generics business rocketed 79%, boosted by expanded reach. Profitability...
**Financial Highlights:** Innova Captab's Q1 FY26 revenue rose 19% YoY to ₹351.5 Cr. EBITDA jumped 28% to ₹56.6 Cr (16.1% margin). PAT grew 5% to ₹31.0 Cr (8.8% margin), impacted by higher depreciation/finance costs. CDMO revenue (71% of total) grew 8%, while Branded Generics soared 59%. Exports accounted for 70%...
Innova Captab Limited is demonstrating strong operational resilience and strategic growth as highlighted in its recent investor presentation for the quarter and nine months ended December 31, 2024. The company reported total income of ₹1,094 crores, with a profit after tax (PAT) of ₹94 crores, marking a 36.3% year-over-year increase...